Search

Displaying results 7821 - 7830 of 10000 in total
  1. Drug

    Ticlatone

    go.drugbank.com/drugs/DB13613
    Experimental

    Categories: Antifungals for Topical Use, Antifungals for Dermatological Use
  2. Drug

    Tolciclate

    go.drugbank.com/drugs/DB13360
    Experimental

    Categories: Antifungals for Topical Use, Antifungals for Dermatological Use
  3. Drug

    Mevidalen

    go.drugbank.com/drugs/DB19034
    Investigational

    Mevidalen is under investigation in clinical trial NCT03305809 (A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or

  4. Drug

    Flunoxaprofen

    go.drugbank.com/drugs/DB13317
    Experimental

    Categories: Antiinflammatory Products for Vaginal Administration, Analgesics, Non-Narcotic
  5. Drug

    ARG201

    go.drugbank.com/drugs/DB06621
    Experimental

    ARG201, a bovine-derived Type I collagen, aims to induce immune tolerance in patients with Diffuse Systemic Scleroderma (dcSSc). … This drug was investigated in the completed clinical trial NCT0000567 (Multicenter Phase II Trial of Oral Type I Bovine Collagen in Scleroderma)

  6. Drug

    TNP-2092

    go.drugbank.com/drugs/DB16312
    Investigational

    TNP-2092 is under investigation in clinical trial NCT03964493 (TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection).

    Categories: Heterocyclic Compounds with 4 or More Rings
  7. Drug

    Recombinant Human Thrombopoietin

    go.drugbank.com/drugs/DB16364
    Investigational

    [A225691, A225696] This drug is used in the treatment of thrombocytopenia. … Recombinant human thrombopoietin is a full-length glycosylated cytokine produced by Chinese hamster ovary cells and is used to promote the generation of megakaryocytes and platelets.

  8. Drug

    AGA2115

    go.drugbank.com/drugs/DB17840
    Investigational

    Developed by Angitia Biopharmaceuticals, AGA2115 is being investigated for the treatment of osteogenesis imperfect.[L46646] … AGA2115 is a humanized bispecific antibody neutralizing both sclerostin and Dickkopf-1.

  9. Drug

    Bilberry

    go.drugbank.com/drugs/DB14235
    ApprovedWithdrawn

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
  10. Drug

    Iobenzamic acid

    go.drugbank.com/drugs/DB13428
    Experimental

    Categories: Compounds used in a research, industrial, or household setting, X-Ray Contrast Media, Iodinated